Laurence Turka

Laurence Turka

Corporate Officer/Principal presso
Immune Tolerance Network
68 anni
Commercial Services
Health Technology
Consumer Services

Profilo

Laurence Turka is the founder of Rheos Medicines, Inc. which was founded in 2018.
He is currently the Deputy Director at Immune Tolerance Network.
He is also a Member of the Association of American Physicians since 2003 and a Member of the American Society for Clinical Investigation since 1995.
Dr. Turka has held several former positions including Chairman-Scientific Counselors at the National Institute of Allergy & Infectious Diseases, President at The American Society of Transplantation, Professor at Harvard Medical School, and Editor in Chief at The Journal of Clinical Investigation.
Dr. Turka received his doctorate degree from Yale School of Medicine.
Additionally, Dr. Turka was the Chief Scientific Officer & Head-Research at Rubius Therapeutics, Inc. from 2021 to 2023.

Posizioni attive di Laurence Turka

SocietàPosizioneInizio
Corporate Officer/Principal -
Corporate Officer/Principal 01/01/1995
Corporate Officer/Principal 01/01/2003

Precedenti posizioni note di Laurence Turka

SocietàPosizioneFine
RUBIUS THERAPEUTICS Direttore Tecnico/Scientifico/R&S 31/01/2023
Fondatore 01/01/2020
Corporate Officer/Principal -
Corporate Officer/Principal -
Presidente -
Vedi nel dettaglio l'esperienza di Laurence Turka

Formazione di Laurence Turka

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

48

Relazioni di 1° grado

10

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private10

Commercial Services

Health Technology

Government

Commercial Services

Consumer Services

Commercial Services

Commercial Services

Consumer Services

Health Technology

Health Technology

  1. Mercati
  2. Insiders
  3. Laurence Turka
- 40%: I migliori strumenti riservati agli abbonati per individuare le opportunità di investimento di domani.
g
:
:
ENTRA ORA